| Literature DB >> 29184443 |
Noralie H Geessink1,2, Yvonne Schoon1,2, Marcel Gm Olde Rikkert1, Harry van Goor3.
Abstract
OBJECTIVE: Treatment decision-making in older patients with colorectal (CRC) or pancreatic cancer (PC) needs improvement. We introduced the EASYcare in Geriatric Onco-surgery (EASY-GO) intervention to optimize the shared decision-making (SDM) process among these patients.Entities:
Keywords: colorectal cancer; elderly; pancreatic cancer; shared decision making; surgeons; training program
Year: 2017 PMID: 29184443 PMCID: PMC5689024 DOI: 10.2147/CMAR.S147312
Source DB: PubMed Journal: Cancer Manag Res ISSN: 1179-1322 Impact factor: 3.989
Figure 1EASY-GO intervention positioned in EASY-GO pilot study.
Abbreviations: EASY-GO, EASYcare in Geriatric Onco-surgery; EASYcare, Elderly Assessment System care; GDS-15, Geriatric Depression Scale, 15 items; MMSE, Mini-Mental State Examination; SDM, shared decision-making.
Figure 2Flowchart that explains the number of surgeons and patients included in the study.
Abbreviation: EASY-GO, EASYcare in Geriatric Onco-surgery.
Patient characteristics before and after implementation of the EASY-GO intervention
| Patient characteristics | Before
| After
| |||
|---|---|---|---|---|---|
| Total n | Mean (SD) | Total n | Mean (SD) | ||
| Age (years) | 19 | 71.1 (5.9) | 19 | 72.1 (4.4) | 0.56 |
| Mean total number of medicines | 18 | 5.8 (3.1) | 18 | 5.9 (3.7) | 0.92 |
| CIRS-G (total score) | 18 | 11.8 (4.8) | 19 | 13.5 (4.0) | 0.24 |
| KATZ-15 | |||||
| T0 | 17 | 0.6 (1.5) | 15 | 1.2 (2.5) | 0.36 |
| T1 | 15 | 1.5 (2.6) | 14 | 1.5 (3.2) | 0.98 |
| EQ5D | |||||
| T0 | 16 | 0.7 (0.4) | 15 | 0.8 (0.3) | 0.51 |
| T1 | 15 | 0.7 (0.3) | 14 | 0.7 (0.4) | 0.86 |
| Length of hospital stay (days) | 11 | 13.3 (10.5) | 14 | 12.2 (6.7) | 0.76 |
| Mean total duration consultations (minutes) | 16 | 35.8 (14.9) | 16 | 36.2 (16.2) | 0.94 |
|
| |||||
|
| |||||
| Sex (female) | 19 | 9 (47.4) | 19 | 6 (31.6) | 0.32 |
| Education level | 17 | 19 | 0.86 | ||
| Low (Verhage 1–4) | 11 (54.7) | 11(57.9) | |||
| Middle (Verhage 5–6) | 5 (29.4) | 6 (31.6) | |||
| High (Verhage 7) | 1 (5.9) | 2 (10.5) | |||
| Poly-pharmacy (≥5 medicines) | 18 | 14 (77.8) | 18 | 14 (77.8) | 1.00 |
| Diagnosis | 19 | 19 | 0.49 | ||
| PC | 14 (73.7) | 13 (68.4) | |||
| CRC | 4 (21.1) | 6 (31.6) | |||
| Others | 1 (5.3) | 0 (0.0) | |||
| Diagnosis | 19 | 19 | 0.34 | ||
| Malignant | 13 (68.4) | 17 (89.5) | |||
| Pre-malignant | 4 (21.1) | 1 (5.3) | |||
| Benign | 1 (5.3) | 0 (0.0) | |||
| At risk | 1 (5.3) | 1 (5.3) | |||
| Cancer stages (CRC) | 4 | 6 | 0.31 | ||
| 0 | 0 (0.0%) | 1 (16.7%) | |||
| I | 1 (25.0%) | 1 (16.7%) | |||
| II | 2 (50.0%) | 0 (0.0%) | |||
| III | 0 (0.0%) | 1 (16.7%) | |||
| IV | 1 (25.0%) | 3 (50.0%) | |||
| Cancer stages (PC) | |||||
| 0 | 14 | 1 (7.1%) | 13 | 0 (0.0%) | 0.45 |
| IA | 0 (0.0%) | 0 (0.0%) | |||
| IB | 0 (0.0%) | 3 (23.1%) | |||
| IIA | 1 (7.1%%) | 2 (15.4%) | |||
| IIB | 2 (14.3%) | 3 (23.1%) | |||
| III | 2 (14.3%) | 2 (15.4%) | |||
| IV | 2 (14.3%) | 1 (7.7%) | |||
| IPMN/NET | 3 (21.4%) | 1 (7.7%) | |||
| SCA/SCN | 1 (7.1%%) | 1 (7.7%) | |||
| Unknown | 2 (14.3%) | 0 (0.0%) | |||
| Treatment (primary) | 19 | 19 | 0.59 | ||
| Surgery (i.e. after neo-adjuvant therapy) | 9 (47.4) | 12 (63.2) | |||
| Radiotherapy and/or systemic therapy (neo-adjuvant) | 1 (5.3) | 2 (10.5) | |||
| Expectative | 4 (21.1) | 2 (10.5) | |||
| Palliative/palliative systemic therapy | 2 (10.5) | 2 (10.5) | |||
| TEM/EMR | 0 (0.0) | 1 (5.3) | |||
| Refrained from treatment by the patient | 1 (5.3) | 0 (0.0) | |||
| Unknown | 1 (5.3) | 0 (0.0) | |||
| Complications (within 30 days after surgery) | 11 | 6 (54.5) | 15 | 11 (73.3) | 0.32 |
| Number of unplanned readmissions (within 30 days after surgery) | 11 | 3 (27.3) | 15 | 2 (13.3) | 0.37 |
| ER visits (unplanned, due to the operation/tumor) | 9 | 5 (55.6) | 15 | 4 (26.7) | 0.16 |
| ICU admission after surgery | 11 | 5 (45.5) | 15 | 10 (66.7) | 0.28 |
| Adjuvant systemic therapy | 14 | 12 | 0.07 | ||
| No | 11 (78.6) | 5 (41.7) | |||
| Yes | 3 (21.4) | 4 (33.3) | |||
| Indicated, but refrained from by the patient | 0 (0.0) | 3 (25.0) | |||
| Mortality (within 30 days after SDM process) | 16 | 4 (25.0) | 16 | 5 (31.3) | 0.69 |
| Type of surgeons | 18 | 19 | 0.16 | ||
| Senior consultant | 14 (77.8) | 12 (63.2) | |||
| Junior consultant | 2 (11.1) | 6 (31.6) | |||
| Surgical resident | 2 (11.1) | 0 (0.0) | |||
| Combination | 0 (0.0) | 1 (5.3) | |||
| Physician sex (female) | 18 | 7 (38.9) | 19 | 8 (42.1) | 0.84 |
| Total number of conversations | 19 | 19 | 0.25 | ||
| 0 | 1 (5.3) | 0 (0.0) | |||
| 1 | 6 (31.6) | 4 (21.1) | |||
| ≥2 | 12 (63.1) | 15 (78.9) | |||
Notes:
p-values were based on Student’s t-test for continuous data, chi-square test for categorical data, and Fisher’s exact test in case of small numbers per category;
based on the clinical TNM classification.
Abbreviations: CIRS-G, Cumulative Illness Rating Scale for Geriatric patients; CRC, colorectal cancer; EASY-GO, EASYcare in Geriatric Onco-surgery; EMR, endoscopic mucosal resection; EQ5D, EuroQol five dimensional scale (scale: −0.33–1.00, where 1 indicates the highest quality of life); ER, emergency room; ICU, intensive care unit; IMPN/NET, intraductal papillary mucinous neoplasm/neuroendocrine tumor; KATZ-15, KATZ index of independence in activities and instrumental activities in daily living (scale 0–15, where 15 indicates the most disabilities); PC, pancreatic cancer; SCA/SCN, serous cystic neoplasm/serous cystadenoma; SDM, shared decision-making; TEM, transanal endoscopic microsurgery. T0, the baseline questionnaire was filled in after the final consultations when the treatment decision was made; T1, the follow-up questionnaire was filled in after three months;
Primary and secondary outcomes before and after implementation of the EASY-GO intervention
| Before
| After
| Difference score | 95% CI of difference score | |||
|---|---|---|---|---|---|---|
| n | Mean±SD | n | Mean±SD | |||
| SDM-Q-9 | 17 | 74.5±27.8 | 15 | 83.6±15.4 | 9.05 | [−7.5; 25.6] |
| VAS-I | 17 | 7.8±2.3 | 15 | 8.2±1.9 | 0.39 | [−1.1; 1.9] |
| VAS-Idoc | 17 | 7.0±1.6 | 19 | 7.5±2.0 | 0.53 | [−0.7; 1.8] |
| VAS-S | 17 | 8.0±1.4 | 15 | 8.6±1.6 | 0.58 | [−0.5; 1.7] |
| DRS | 15 | 28.3±20.7 | 14 | 19.6±21.4 | −8.69 | [−24.7; 7.4] |
| Δ EQ5D | 14 | −0.1±0.3 | 12 | −0.1±0.2 | −0.04 | [−0.3; 0.2] |
| Δ KATZ-15 | 15 | 1.1±2.5 | 12 | 0.3±1.2 | −0.73 | [−2.4; 0.9] |
Abbreviations: DRS, Decisional Regret Scale (range 0–100, where 100 indicates the highest level of regret); EASY-GO, EASYcare in Geriatric Onco-surgery; SDM-Q-9, nine-item Shared Decision Making Questionnaire (range 0–100, where 100 indicates the highest extent of SDM); VAS-I, patient involvement on a visual analog scale (range 0–10, where 10 indicates the best score); VAS-Idoc: patient involvement on a visual analog scale according to the physician (range 0–10, where 10 indicates the best score); VAS-S, patient satisfaction on a visual analog scale (range 0–10, where 10 indicates the best score); Δ EQ5D, change in EuroQol five dimensional scale (scale: −0.33–1.00, where 1 indicates the highest quality of life) between T1 and T0; Δ KATZ-15, change in KATZ index of independence in activities and instrumental activities in daily living (15 items, where 15 indicates the most disabilities) between T1 and T0.
Primary and secondary outcomes per diagnosis before and after implementation of the EASY-GO intervention
| PC | Before
| After
| Difference score | 95% CI of difference score | ||
|---|---|---|---|---|---|---|
| n | Mean±SD | n | Mean±SD | |||
| SDM-Q-9 | 12 | 74.6±30.1 | 10 | 88.0±12.3 | 13.37 | [−7.9; 34.6] |
| VAS-I | 12 | 8.5±1.3 | 10 | 8.7±1.8 | 0.27 | [−1.1; 1.6] |
| VAS-Idoc | 13 | 6.6±1.7 | 13 | 7.9±0.6 | 1.23 | [0.2; 2.2] |
| VAS-S | 12 | 8.0±1.6 | 10 | 8.9±1.4 | 0.88 | [−0.5; 2.2] |
| DRS | 11 | 26.8±21.5 | 10 | 16.5±16.0 | −10.32 | [−27.8; 7.1] |
| Δ EQ5D | 10 | −0.0±0.4 | 8 | −0.1±0.3 | −0.11 | [−0.5; 0.2] |
| Δ KATZ-15 | 11 | 1.5±2.9 | 8 | 0.3±1.3 | −1.20 | [−3.5; 1.1] |
|
| ||||||
|
| ||||||
| SDM-Q-9 | 4 | 69.4±18.4 | 5 | 74.7±18.4 | 5.22 | [−29.5; 40.0] |
| VAS-I | 4 | 5.4±3.4 | 5 | 7.0±1.6 | 1.63 | [−2.4; 5.6] |
| VAS-Idoc | 4 | 8.2±1.1 | 6 | 6.8±3.5 | −1.39 | [−5.6; 2.8] |
| VAS-S | 4 | 8.0±1.1 | 5 | 8.0±1.9 | 0.00 | [−2.5; 2.5] |
| DRS | 3 | 23.3±11.5 | 4 | 27.5±33.3 | 4.17 | [−48.5; 56.8] |
| Δ EQ5D | 3 | −0.2±0.2 | 4 | −0.0±0.2 | 0.16 | [−0.2; 0.5] |
| Δ KATZ-15 | 3 | 0.0±0.0 | 4 | 0.5±1.0 | 0.50 | [−1.0; 2.0] |
Abbreviations: CRC, colorectal cancer; DRS, Decisional Regret Scale (range 0–100, where 100 indicates the highest level of regret); EASY-GO, EASYcare in Geriatric Onco-surgery; PC, pancreatic cancer; SDM-Q-9, nine-item Shared Decision Making Questionnaire (range 0–100, where 100 indicates the highest extent of SDM); VAS-I, patient involvement in the decision-making process on a visual analog scale (range 0–10, where 10 indicates the best score); VAS-Idoc, patient involvement in the decision-making process on a visual analog scale according to the physician (range 0–10, where 10 indicates the best score), VAS-S, patient satisfaction concerning the decision-making process on a visual analog scale (range 0–10, where 10 indicates the best score); Δ EQ5D, change in EuroQol five dimensional scale (scale: −0.33–1.00, where 1 indicates the highest quality of life) between T1 and T0; Δ KATZ-15, change in KATZ index of independence in activities and instrumental activities in daily living (15 items, where 15 indicates the most disabilities) between T1 and T0.